The Mechanisms of CD8+ T Cells in Kidney Injury
Year: 2026
Type: article
Abstract: Kidney injury encompasses a range of pathological conditions including acute kidney injury (AKI), chronic kidney disease (CKD), and the transition from AKI to CKD. Given its multifactorial pathogenesis, dismal clinical outcomes, and the paucity of effective targeted therapies, renal injury constitutes a substantial global public health burden. As a core effector of adaptive immunity, CD8+ T cells not only participate in the body’s anti-infection and anti-tumor immune responses, but are also involved throughout the process of kidney injury. Emerging technologies such as single-cell sequencing and immune gene editing are now revealing the bidirectional roles and subset diversity of CD8+ T cells in renal injury. Accumulating evidence suggests that CD8+ T cells may contribute to kidney injury progression in specific experimental and clinical contexts via diverse mechanisms, including direct cytotoxicity against renal parenchymal cells, secretion of pro-inflammatory and pro-fibrotic mediators, remodeling of the local immune microenvironment, and induction of microvascular damage. Meanwhile, their regulatory subsets curb overt inflammation, retard fibrosis, and preserve renal function. This review surveys the biology and subset heterogeneity of CD8+ T cells, recapitulates their involvement in AKI, CKD, and disease transition, evaluates targeted immunotherapies and translational progress, and highlights unresolved issues and future priorities, with the goal of informing mechanistic studies and precision management of renal injury.
Institution: Hebei University of Chinese Medicine
Language: English
Topic: Acute Kidney Injury Research
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,499
Awards: G8031123151, G9001373072
OpenAlex ID: W7233888544
